N1-Benzyl-N1-[(4-chlorophenyl)methyl]-N4-[(oxolan-2-YL)methyl]benzene-1,4-disulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N1-Benzyl-N1-[(4-chlorophenyl)methyl]-N4-[(oxolan-2-YL)methyl]benzene-1,4-disulfonamide
• 英文别名: 4-N-benzyl-4-N-[(4-chlorophenyl)methyl]-1-N-(oxolan-2-ylmethyl)benzene-1,4-disulfonamide
• 化学式: C₂₅H₂₇ClN₂O₅S₂
• 分子量: 535.1
• InChiKey: UEHBAOHVIQAFSS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  35
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  110
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• [EN] BENZENE DISULFONAMIDE FOR THE TREATMENT OF CANCER<br/>[FR] BENZÈNEDISULFONAMIDE POUR LE TRAITEMENT DU CANCER
  申请人：MAX PLANCK GESELLSCHAFT

  公开号：WO2018130625A1

  公开（公告）日：2018-07-19

  The present invention relates to novel substituted benzene disulfonamides, as well as pharmaceutical compositions containing at least one of these substituted benzene disulfonamides together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said substituted benzene disulfonamides are binding to the prenyl binding pocket of PDE6δ and therefore, are useful for the prophylaxis and treatment of cancer by inhibition of the binding of PDE6δ to farnesylated Ras proteins and thereby, inhibition of oncogenic Ras signaling in cells.

  本发明涉及新型取代苯二磺胺基化合物，以及包含至少一种这些取代苯二磺胺基化合物的药物组合物，与至少一种药用可接受载体、赋形剂和/或稀释剂一起。所述取代苯二磺胺基化合物结合到PDE6δ的萜基结合口袋，因此，通过抑制PDE6δ与法尼基化的Ras蛋白的结合，从而抑制细胞中致癌Ras信号传导，对癌症的预防和治疗具有用处。
• BENZENE DISULFONAMIDE FOR THE TREATMENT OF CANCER
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP3351544A1

  公开（公告）日：2018-07-25

  The present invention relates to novel substituted benzene disulfonamides of formula (I), as well as pharmaceutical compositions containing at least one of these substituted benzene disulfonamides together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said substituted benzene disulfonamides are binding to the prenyl binding pocket of PDE6δ and therefore, are useful for the prophylaxis and treatment of cancer by inhibition of the binding of PDE6δ to farnesylated Ras proteins and thereby, inhibition of oncogenic Ras signaling in cells.

  本发明涉及式（I）的新型取代苯二磺酰胺类化合物，以及含有至少一种此类取代苯二磺酰胺类化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的药物组合物。所述取代苯二磺酰胺与 PDE6δ 的芳基结合口袋结合，因此，通过抑制 PDE6δ 与法尼基化的 Ras 蛋白结合，从而抑制细胞中致癌的 Ras 信号传导，可用于预防和治疗癌症。
• Benzene disulfonamide for the treatment of cancer
  申请人：Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

  公开号：US10913710B2

  公开（公告）日：2021-02-09

  The present invention relates to novel substituted benzene disulfonamides, as well as pharmaceutical compositions containing at least one of these substituted benzene disulfonamides together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said substituted benzene disulfonamides are binding to the prenyl binding pocket of PDE6δ and therefore, are useful for the prophylaxis and treatment of cancer by inhibition of the binding of PDE6δ to farnesylated Ras proteins and thereby, inhibition of oncogenic Ras signaling in cells.

  本发明涉及新型取代苯二磺酰胺类化合物，以及含有至少一种此类取代苯二磺酰胺类化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的药物组合物。所述取代苯二磺酰胺类药物与 PDE6δ 的芳基结合口袋结合，因此，通过抑制 PDE6δ 与法尼基化 Ras 蛋白的结合，从而抑制细胞中致癌的 Ras 信号传导，可用于预防和治疗癌症。